Getting healthcare innovation paid for, and to market.
A senior, partner-led advisory firm guiding pharmaceutical, medical device, and clinical diagnostic companies — and the investors who back them — through reimbursement, market access, and due diligence.
Three disciplines, one continuum.
Engaged individually or end-to-end — from first-in-class coding strategy to investor-grade diligence.
Coding & Reimbursement Support
Medical coding, payer coverage, and payment pathways — grounded in healthcare policy — so products get reimbursed.
Market Access
Pharma market access: payer strategy, pricing, evidence, and access planning to launch and scale.
Due Diligence
Reimbursement and commercial diligence for VCs, PE sponsors, and investment banks — FDA pathway to revenue.
Boutique by design. Senior at every seat.
Deep reimbursement expertise
Decades inside coding, coverage, and payment — across CMS, commercial payers, and PBMs.
Partner-led, every engagement
You work directly with senior practitioners — never handed to a junior team.
Across pharma, device, and clinical diagnostics
Pattern recognition across modalities, from LDTs to durable devices to specialty therapeutics.
Investor-grade rigor
Diligence and strategy work trusted by VC, PE, and investment banking teams.
Outcomes that move products forward.
Kent McKinney
Founder & Principal
Kent founded Wellguidant Advisors to bring senior, specialized reimbursement counsel to companies and investors navigating healthcare's most consequential commercialization decisions.
About the firm →Let's discuss your reimbursement and access strategy.
Senior, partner-led engagements. Confidential by default.